UC San Diego researchers reverse pulmonary arterial hypertension in mouse models

		IMAGE: This is surgeon and scientist Patricia A. Thistlethwaite, M.D., Ph.D., of University of California, San Diego. Click here for more information.

Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice. This groundbreaking discovery has implications for future drug therapies that may extend the life of patients with pulmonary arterial hypertension and prevent the need for lung transplantation, currently the only cure for this debilitating disease.